Gene · 9401
Papers1,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer. | Sci Rep | 2023 | 37932350 | PubTator, text mining | PubMed |
| Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China. | Front Oncol | 2023 | 37901334 | PubTator, text mining | PubMed |
| Evaluation of Liftover Tools for the Conversion of Genome Reference Consortium Human Build 37 to Build 38 Using ClinVar Variants. | Genes (Basel) | 2023 | 37895222 | PubTator, text mining | PubMed |
| Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids? | Cancers (Basel) | 2023 | 37894411 | PubTator, text mining | PubMed |
| Recognition and coacervation of G-quadruplexes by a multifunctional disordered region in RECQ4 helicase. | Nat Commun | 2023 | 37875529 | PubTator, text mining | PubMed |
| Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer. | Clin Cancer Res | 2023 | 37870965 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes. | Int J Mol Sci | 2023 | 37834388 | PubTator, text mining | PubMed |
| DDX52 gene expression in LUAD tissues indicates potential as a prognostic biomarker and therapeutic target. | Sci Rep | 2023 | 37833424 | PubTator, text mining | PubMed |
| G-quadruplexes of KSHV oriLyt play important roles in promoting lytic DNA replication. | Microbiol Spectr | 2023 | 37800915 | PubTator, text mining | PubMed |
| Uncovering structural variants associated with body weight and obesity risk in labrador retrievers: a genome-wide study. | Front Genet | 2023 | 37799139 | PubTator, text mining | PubMed |
| Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors. | JCI Insight | 2023 | 37796616 | PubTator, text mining | PubMed |
| Congenital Telangiectatic Erythema: Scoping Review. | JMIR Dermatol | 2023 | 37796556 | PubTator, text mining | PubMed |
| Replication-induced DNA secondary structures drive fork uncoupling and breakage. | EMBO J | 2023 | 37781931 | PubTator, text mining | PubMed |
| Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients. | Int J Mol Sci | 2023 | 37762649 | PubTator, text mining | PubMed |
| Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium-177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience. | Cancers (Basel) | 2023 | 37760475 | PubTator, text mining | PubMed |
| Literature-Based Discovery to Elucidate the Biological Links between Resistant Hypertension and COVID-19. | Biology (Basel) | 2023 | 37759668 | PubTator, text mining | PubMed |
| Identification of M2-like macrophage-related signature for predicting the prognosis, ecosystem and immunotherapy response in hepatocellular carcinoma. | PLoS One | 2023 | 37725627 | PubTator, text mining | PubMed |
| Large-scale phenogenomic analysis of human cancers uncovers frequent alterations affecting SMC5/6 complex components in breast cancer. | NAR Cancer | 2023 | 37705607 | PubTator, text mining | PubMed |
| Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. | Cancers (Basel) | 2023 | 37686696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9401/papers?page=7